Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
D015119:Aminocaproic Acid / Q000494:pharmacology; D000818:Animals; D002264:Carboxylic Acids / Q000494:pharmacology*; D002417:Cattle; D010450:Endopeptidases / Q000494:pharmacology*; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D010958:Plasminogen / Q000378:metabolism*; D010960:Plasminogen Activators / Q000494:pharmacology*; D013552:Swine; D014361:Trypsin Inhibitors / Q000494:pharmacology*; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology*
D002264:Carboxylic Acids; D014361:Trypsin Inhibitors; D005337:Fibrin; D010958:Plasminogen; D010450:Endopeptidases; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator; D015119:Aminocaproic Acid